Market Overview:

Global Surgical Sealants and Adhesives Market was valued at USD 205 Million in 2018 and it is expected to reach USD 361 Million with a CAGR of 9.6% by 2023. Adhesives and sealants are used during surgical procedures to reinforce surgical wounds, repair injured tissues or even replace common suturing techniques. These can be developed naturally or synthetically.

Request Report Sample:  https://marketdataforecast.com/market-reports/surgical-sealants-and-adhesives-market-3142/request-sample

Factors affecting market growth:

Increasing need to manage blood loss in patients. (+)
Rise in geriatric population (+)
Patients suffering with chronic diseases are increased (+)
Adoption of advanced technology (+)
Clinical data requirements for product approvals (-)
Lack of awareness and relatively lower disposable income. (-)
Get your customized report: https://marketdataforecast.com/market-reports/surgical-sealants-and-adhesives-market-3142/customize-report

Market Segmentation

The Global Surgical Sealants and Adhesives Market is segmented on the basis of

Product

Natural & Synthetic
Fibrin
Collagen
Gelatine
Cyanoacrylate
Albumin
Human Blood
Indication

Haemostasis
Tissue Sealing
Application

CNS
Cardiovascular
Cosmetic Surgery
The Gelatine segment is estimated to grow at the highest CAGR during the aforementioned forecast period because of their tensile strength. Tissue sealing is the second highest growth market for surgical sealants and adhesives.

Browse full Table of Contents: https://marketdataforecast.com/market-reports/surgical-sealants-and-adhesives-market-3142/

Key players:

Key players in these market are CryoLife, Inc. (U.S.), Johnson & Johnson (Ethicon, Inc., Baxter International, Inc. (U.S.), and C.R. Bard, Inc. (U.S.) held the key share of the surgical sealants and adhesives market and are likely continue to dominate the market between 2016 and 2021. Some of the primary players operating in this market are Cohera Medical, Inc. (U.S.), Ocular Therapuetix, Inc. (U.S.), Vivostat A/S (Denmark), and Sealantis Ltd. (Israel), Medtronic plc (U.S.), Sanofi Group (France), B. Braun Melsungen AG (Germany).